Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DAPAGLIFLOZIN PROPANEDIOL Cause Pollakiuria? 388 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 388 reports of Pollakiuria have been filed in association with DAPAGLIFLOZIN PROPANEDIOL (FARXIGA). This represents 2.3% of all adverse event reports for DAPAGLIFLOZIN PROPANEDIOL.

388
Reports of Pollakiuria with DAPAGLIFLOZIN PROPANEDIOL
2.3%
of all DAPAGLIFLOZIN PROPANEDIOL reports
1
Deaths
20
Hospitalizations

How Dangerous Is Pollakiuria From DAPAGLIFLOZIN PROPANEDIOL?

Of the 388 reports, 1 (0.3%) resulted in death, 20 (5.2%) required hospitalization, and 5 (1.3%) were considered life-threatening.

Is Pollakiuria Listed in the Official Label?

Yes, Pollakiuria is listed as a known adverse reaction in the official FDA drug label for DAPAGLIFLOZIN PROPANEDIOL.

What Other Side Effects Does DAPAGLIFLOZIN PROPANEDIOL Cause?

Death (3,443) Fungal infection (1,204) Blood glucose increased (778) Weight decreased (777) Urinary tract infection (583) Dizziness (582) Diabetic ketoacidosis (547) Nausea (460) Fatigue (442) Cerebrovascular accident (352)

What Other Drugs Cause Pollakiuria?

EMPAGLIFLOZIN (944) SACUBITRIL\VALSARTAN (820) ADALIMUMAB (686) MIRABEGRON (644) RELUGOLIX (559) LENALIDOMIDE (474) CANAGLIFLOZIN (466) LEUPROLIDE (454) OMEPRAZOLE (434) TOFACITINIB (410)

Which DAPAGLIFLOZIN PROPANEDIOL Alternatives Have Lower Pollakiuria Risk?

DAPAGLIFLOZIN PROPANEDIOL vs DAPAGLIFLOZIN PROPANEDIOL\METFORMIN DAPAGLIFLOZIN PROPANEDIOL vs DAPRODUSTAT DAPAGLIFLOZIN PROPANEDIOL vs DAPSONE DAPAGLIFLOZIN PROPANEDIOL vs DAPTOMYCIN DAPAGLIFLOZIN PROPANEDIOL vs DARATUMUMAB

Related Pages

DAPAGLIFLOZIN PROPANEDIOL Full Profile All Pollakiuria Reports All Drugs Causing Pollakiuria DAPAGLIFLOZIN PROPANEDIOL Demographics